
The CHMP (Committee for Medicinal Products for Human use) did not have many drugs to consider in July.
The European Medicines Agency's expert panel only made recommendations in the case of three drugs. Of these, two were recommended for approval, whilst a negative opinion was adopted for the third.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app